Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Basiliximab for Renal Recovery Post-Liver Transplant
NCT04104438Phase 4Completed
- Start
- Jan 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in liver transplantation, Renal Insufficiency (RI). Started Jan 2021; status: completed.
02
Drugs
everolimus
03
Conditions
liver transplantationRenal Insufficiency (RI)
Beyond the preview
Go deeper on NCT04104438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104438.